Altogether, we assembled a comprehensive annotation of CRC-CD8+ T cells that spanned across tumor subtype pathology (MSI vs MSS), patient geographical origin (3 countries across two continents) and dataset heterogeneity (5 cohorts). The gene discussed is CD8A; the disease is neoplasm.